OSferionBiomaterials Corp. and Japan Tissue Engineering Co., Ltd. form business alliance to develop knee joint preservation treatment combining regenerative medicine and osteotomy.
Press ReleaseOSferionBiomaterials Corp.OSferionBiomaterials Corp. (Headquarters: Shibuya Ward, Tokyo, President: Manabu Ishikawa, hereinafter referred to as OSB) and Japan Tissue Engineering Co., Ltd. (Headquarters: Gamagori City, Aichi Prefecture, President: Kazuto Yamada, hereinafter referred to as J-TEC) have entered into a business alliance agreement to promote a treatment option for osteoarthritis of the knee that combines regenerative medicine and osteotomy. The two companies will begin mutual product development and joint promotions from August 2026.
*For more detail information (External Link) (in Japanese) : オスフェリオンバイオマテリアルとジャパン・ティッシュエンジニアリング再生医療と骨切り術を組み合わせた膝関節温存治療に向け業務提携 | お知らせ | オスフェリオンバイオマテリアル株式会社